Go Pro

Definitive Healthcare (DH) Stock Price, News & Analysis

Definitive Healthcare logo
$0.80 -0.01 (-1.47%)
As of 08/28/2026 04:00 PM Eastern

About Definitive Healthcare Stock (NASDAQ:DH)

Advanced

Key Stats

Today's Range
$0.76
$0.84
50-Day Range
$0.63
$0.90
52-Week Range
$0.61
$4.35
Volume
190,837 shs
Average Volume
233,915 shs
Market Capitalization
$85.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.47
Consensus Rating
Reduce

Company Overview

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities. Users can access real-time insights into referral patterns, procedure volumes, affiliation networks and payer mix, as well as news alerts and forecasting tools. Definitive Healthcare also provides specialized modules for emerging therapeutic areas, such as oncology and medical device utilization, as well as workflow integrations with customer relationship management (CRM) and business intelligence (BI) systems.

Founded in 2011 by Brian Atwood, Definitive Healthcare has grown organically and through strategic acquisitions to broaden its content, geographies and analytical capabilities. The company completed its initial public offering in July 2021, marking a milestone in its expansion journey. It maintains headquarters in Nashville, Tennessee, and operates additional offices in North America and Europe to support a global customer base.

Leadership at Definitive Healthcare is anchored by founder and Chief Executive Officer Brian Atwood, who oversees the company’s product strategy, data operations and go-to-market initiatives. Under his direction, the management team has focused on fostering a data-driven culture, forging partnerships with key industry stakeholders and investing in advanced analytics to address the evolving needs of healthcare and life sciences organizations worldwide.

AI Generated. May Contain Errors.

Definitive Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

DH MarketRank™: 

Definitive Healthcare scored higher than 51% of companies evaluated by MarketBeat, and ranked 566th out of 919 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Definitive Healthcare has received a consensus rating of Reduce. The company's average rating score is 1.89, and is based on 1 strong buy rating, no buy ratings, 5 hold ratings, and 3 sell ratings.

  • Upside Potential

    Definitive Healthcare has a consensus price target of $1.47, representing about 83.4% upside from its current price of $0.80.

  • Amount of Analyst Coverage

    Definitive Healthcare has only been the subject of 4 research reports in the past 90 days.

  • Read more about Definitive Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Definitive Healthcare are expected to decrease by -33.33% in the coming year, from $0.06 to $0.04 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Definitive Healthcare is -0.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Definitive Healthcare is -0.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Definitive Healthcare has a PEG Ratio of 9.90. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Definitive Healthcare has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Definitive Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    2.33% of the float of Definitive Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Definitive Healthcare has a short interest ratio ("days to cover") of 8.53.
  • Change versus previous month

    Short interest in Definitive Healthcare has recently increased by 4.66%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Definitive Healthcare does not currently pay a dividend.

  • Dividend Growth

    Definitive Healthcare does not have a long track record of dividend growth.

  • News Sentiment

    Definitive Healthcare has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.94 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Definitive Healthcare this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Definitive Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.09% of the stock of Definitive Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    98.67% of the stock of Definitive Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Definitive Healthcare's insider trading history.
Receive DH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DH Stock News Headlines

Definitive Healthcare Corp - Ordinary Shares - Class A
3 Biggest Tech Billionaires Are ALL Backing This Potential $367 Trillion Tech
Elon Musk, Peter Thiel, and Sam Altman are backing a new AI use case discovered at MIT that has already identified potential treatments for dangerous diseases. McKinsey estimates this technology could be 500 times bigger than ChatGPT, while Nature projects it could add $367 trillion to the global economy.tc pixel
Definitive Healthcare Corp
Definitive Healthcare (DH) Q2 2026 Earnings Call
See More Headlines

DH Stock Analysis - Frequently Asked Questions

Definitive Healthcare's stock was trading at $2.87 at the beginning of the year. Since then, DH shares have decreased by 72.0% and is now trading at $0.8024.

Definitive Healthcare Corp. (NASDAQ:DH) released its quarterly earnings data on Monday, August, 10th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.01. The firm had revenue of $55.20 million for the quarter, compared to the consensus estimate of $55.47 million. Definitive Healthcare had a positive trailing twelve-month return on equity of 3.55% and a negative net margin of 72.28%.
Read the conference call transcript
.

Definitive Healthcare (DH) raised $389 million in an IPO on Tuesday, September 14th 2021. The company issued 15,555,555 shares at a price of $24.00-$26.00 per share.

Definitive Healthcare's top institutional shareholders include Corient Private Wealth LP (0.43%) and Williams & Novak LLC (0.07%).
View institutional ownership trends
.

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Definitive Healthcare investors own include AUO (AUOTY), American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), Triple Flag Precious Metals (TFPM) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
8/10/2026
Today
8/29/2026
Next Earnings (Estimated)
11/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NASDAQ:DH
CIK
1861795
Fax
N/A
Employees
970
Year Founded
2011

Price Target and Rating

High Price Target
$3.00
Low Price Target
$0.70
Potential Upside/Downside
+83.4%
Consensus Rating
Reduce
Rating Score (0-4)
1.89
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.60)
Trailing P/E Ratio
N/A
Forward P/E Ratio
13.37
P/E Growth
9.9
Net Income
-$138.93 million
Net Margins
-72.28%
Pretax Margin
-102.30%
Return on Equity
3.55%
Return on Assets
1.63%

Debt

Debt-to-Equity Ratio
0.81
Current Ratio
1.86
Quick Ratio
1.86

Sales & Book Value

Annual Sales
$241.52 million
Price / Sales
0.35
Cash Flow
$1.96 per share
Price / Cash Flow
0.41
Book Value
$1.76 per share
Price / Book
0.46

Miscellaneous

Outstanding Shares
106,750,000
Free Float
88,502,000
Market Cap
$85.66 million
Optionable
Not Optionable
Beta
1.35

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:DH) was last updated on 8/30/2026 by MarketBeat.com Staff.
From Our Partners